Porth Ymchwil

Cyhoeddiadau

Hidlyddion uwch

Pob awdur

Ailosod
i
22801 - 22850 o blith 28,901Maint y tudalen: 50
rss feed
Trefnu yn ôl: Teitl
  1. Cyhoeddwyd

    Cost–effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs

    Hughes, D., Verhof, T. I., Redekop, W. K., van Schie, R. M., Bayat, S., Daly, A. K., Geitona, M., Haschke-Becher, E., Hughes, D. A., Kamali, F., Levin, L. A., Manolopoulos, V. G., Pirmohamed, M., Siebert, U., Stingl, J. C., Wadelius, M., de Boer, A. & Maitland-van der Zee, A. H., 1 Medi 2012, Yn: Pharmacogenomics. 13, 12, t. 1405-1417

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  2. Cyhoeddwyd

    Cost–benefit analysis: a decision-support tool or a venue for contesting ecosystem knowledge?

    Hockley, N., 13 Maw 2014, Yn: Environment and Planning C: Government and Policy. 32, 2, t. 283-300

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  3. Cyhoeddwyd

    Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales

    Pijeira Perez, Y., Wood, E. & Hughes, D., 1 Tach 2023, Yn: Orphanet Journal of Rare Diseases. 18, 1, 342.

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  4. Cyhoeddwyd

    Costs of non-compliance to antipsychotic medications among patients with schizophrenia.

    Hughes, D., Hughes, D. A., Salas, M., Zuluaga, A., Cowell, W., Lebmeier, M., Vardeva, K., Pisu, M. & Shinogle, J., 1 Mai 2008.

    Allbwn ymchwil: Cyfraniad at gynhadledd › Papur

  5. Cyhoeddwyd

    Costs of Medication Nonadherence in Patients with Diabetes Mellitus: A Systematic Review and Critical Analysis of the Literature.

    Hughes, D., Salas, M., Hughes, D. A., Zuluaga, A., Vardeva, K. & Lebmeier, M., 1 Medi 2009, Yn: Value in Health. 12, 6, t. 915-922

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  6. Cyhoeddwyd

    Costs and outcomes of improving population health through better social housing: a cohort study and economic analysis

    Bray, N. J., Burns, P., Jones, A., Winrow, E. & Edwards, R., Rhag 2017, Yn: International Journal of Public Health . 62, 9, t. 1039-1050

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  7. Cyhoeddwyd

    Costs and benefits of invasive exotic plants in the Mediterranean.

    Raquin, A., Edwards-Jones, G., Bardsley, D. & Papanastasis, A. (gol.), 25 Ebr 2004, t. 1-10.

    Allbwn ymchwil: Cyfraniad at gynhadledd › Papur

  8. Cyhoeddwyd

    Cost-utility analysis of public health interventions

    Edwards, R. & Winrow, E., 19 Maw 2019, Applied Health Economics for Public Health Practice and Research . Tudor Edwards, R. & McIntosh, E. (gol.). Oxford University Press, t. 177-203 (Handbooks in Health Economic Evaluation).

    Allbwn ymchwil: Pennod mewn Llyfr/Adroddiad/Trafodion Cynhadledd › Pennod

  9. Cyhoeddwyd

    Cost-utility analysis of osteopathy in primary care: results from a pragmatic randomized controlled trial.

    Linck, P. G., Russell, I. T., Williams, N. H., Edwards, R. T., Linck, P., Muntz, R., Hibbs, R., Wilkinson, C., Russell, I., Russell, D. & Hounsome, B., 1 Rhag 2004, Yn: Family Practice. 21, 6, t. 643-650

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  10. Cyhoeddwyd

    Cost-utility analysis of on-demand rabeprazole and esomeprazole for non-erosive reflux disease

    Hughes, D. & Hughes, D. A., 1 Tach 2003.

    Allbwn ymchwil: Cyfraniad at gynhadledd › Papur

  11. Cyhoeddwyd

    Cost-utility analysis of on-demand rabeprazole and esomeprazole for non-erosive reflux disease

    Hughes, D. & Hughes, D. A., 1 Tach 2003.

    Allbwn ymchwil: Cyfraniad at gynhadledd › Papur

  12. Cyhoeddwyd

    Cost-utility analysis of on demand rabeprazole and esomeprazole for symptomatic gastro oesophageal reflux disease

    Hughes, D., Hughes, D. A. & Dubois, D., 1 Tach 2003, Yn: Value in Health. 6, 6, t. 613

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  13. Cyhoeddwyd

    Cost-effectiveness of yoga for managing musculoskeletal conditions in the workplace

    Hartfiel, E., Clarke, G., Havenhand, J., Phillips, C. & Edwards, R., 30 Rhag 2017, Yn: Occupational Medicine. 67, 9, t. 687-695

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  14. Cyhoeddwyd

    Cost-effectiveness of steroid (methylprednisolone) injections versus anaesthetic alone for the treatment of Morton’s neuroma: economic evaluation alongside a randomised controlled trial (MortISE trial)

    Edwards, R. T., Yeo, S. T., Russell, D., Thomson, C. E., Beggs, I., Gibson, J. N. A., McMillan, D., Martin, D. J. & Russell, I. T., 25 Chwef 2015, Yn: Journal of Foot and Ankle Research. 8, 6, t. article 6 11 t.

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  15. Cyhoeddwyd

    Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy

    Plumpton, C., Yip, V. L. M., Alfirevic, A., Marson, A. G., Pirmohamed, M. & Hughes, D., Ebr 2015, Yn: Epilepsia.

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  16. Cyhoeddwyd

    Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden

    Verhoef, T. I., Redekop, W. K., Langenskiold, S., Kamali, F., Wadelius, M., Burnside, G., Maitland-van der Zee, A. H., Hughes, D. & Pirmohamed, M., Hyd 2016, Yn: The Pharmacogenomics Journal. 16, t. 478–484

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  17. Cyhoeddwyd

    Cost-effectiveness of panel tests for multiple pharmacogenes associated with adverse drug reactions: An evaluation framework

    Plumpton, C., Pirmohamed, M. & Hughes, D., Meh 2019, Yn: Clinical Pharmacology and Therapeutics. 105, 6, t. 1429-1438

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  18. Cyhoeddwyd

    Cost-effectiveness of paediatric central venous catheters in the UK: A secondary publication from the CATCH clinical trial

    Ridyard, C., Plumpton, C., Gilbert, R. E. & Hughes, D., 19 Medi 2017, Yn: Frontiers in Pharmacology. 8, 644.

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  19. Cyhoeddwyd

    Cost-effectiveness of magnetic resonance imaging of the knee for patients presenting in primary care

    Wilkinson, C. E. & DAMASK Direct Access to Magnetic Resonance Imaging Assessment for Suspect Knees Trial Team, N. V., 1 Tach 2008, Yn: British Journal of General Practice. 58, 556, t. e10-e16

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  20. Cyhoeddwyd

    Cost-effectiveness of home versus hospital management of children at onset of Type 1 Diabetes: The DECIDE randomised controlled trial

    McCarroll, Z., Townson, J., Pickles, T., Gregory, J. W., Playle, R., Robling, M. & Hughes, D., 19 Mai 2021, Yn: BMJ Open. 11, 5, e043523.

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  21. Cyhoeddwyd

    Cost-effectiveness of different strategies to manage patients with sciatica

    Fitzimmons, D., Phillips, C. J., Bennett, H., Jones, M., Williams, N. H., Lewis, R., Sutton, A., Matar, H. E., Din, N. U., Burton, K., Nafees, S., Hendry, M., Rickard, I. & Wilkinson, C. E., Gorff 2014, Yn: Pain. 155, 7, t. 1318-1327 10 t.

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  22. Cyhoeddwyd

    Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data.

    Hughes, D., Bodger, K., Kikuchi, T. & Hughes, D. A., 1 Awst 2009, Yn: Alimentary Pharmacology and Therapeutics. 30, 3, t. 265-274

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  23. Cost-effectiveness of a specialist smoking cessation package compared with standard smoking cessation services for people with severe mental illness in England: a trial-based economic evaluation from the SCIMITAR+ study

    Li, J., Fairhurst, C. M., Peckham, E. J., Bailey, D., Arundel, C. E., Hewitt, C. E., Heron, P. N., Crosland, S., Parrott, S., Gilbody, S. & collaborative, SCIMITAR., 7 Hyd 2020, Yn: Addiction. 115, 11, t. 2113-2122

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  24. Cyhoeddwyd

    Cost-effectiveness of a national exercise referral programme for primary care patients in Wales: results of a randomised controlled trial

    Linck, P. G., Williams, N. H., Edwards, R. T., Linck, P., Hounsome, N., Raisanen, L., Williams, N., Moore, L. & Murphy, S., 29 Hyd 2013, Yn: BMC Public Health. 13, t. 1021

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  25. Cyhoeddwyd

    Cost-effectiveness of a combined classroom curriculum and parental intervention: economic evaluation of data from the Steps Towards Alcohol Misuse Prevention Programme cluster randomised controlled trial

    Agus, A., McKay, M., Cole, J. C., Doherty, P., Foxcroft, D., Harvey, S., Murphy, L., Percy, A. & Sumnall, H., 2 Gorff 2019, Yn: BMJ Open. 9, t. e027951 9 t.

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  26. Cyhoeddwyd

    Cost-effectiveness of HLA-B*15:02 screening in Malaysia

    Plumpton, C. & Hughes, D., Hyd 2017, Yn: British Journal of Dermatology. 177, 4, t. 904-905

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Sylw/Dadl

  27. Cyhoeddwyd

    Cost-effectiveness findings from the Agewell pilot study of behaviour change to promote health and wellbeing in later life

    Jones, C. L., Edwards, R. T., Nelis, S. M., Jones, I. R., Hindle, J. V., Thom, J. M., Cooney, J. & Clare, L., 8 Rhag 2015, Yn: Health Economics and Outcome Research: Open Access. 1, 1

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  28. Cyhoeddwyd

    Cost-effectiveness considerations in pharmacogenetics.

    Hughes, D. & Hughes, D. A., 1 Ion 2008.

    Allbwn ymchwil: Cyfraniad at gynhadledd › Papur

  29. Cyhoeddwyd

    Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population

    Asukai, Y., Valladares, A., Camps, C., Wood, E., Taipale, K., Arellano, J., Cassinello, A., Sacristán, J. A. & Dilla, T., 29 Ion 2010, Yn: BMC Cancer. 10, t. 26

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  30. Cyhoeddwyd

    Cost-effectiveness analysis of infliximab and adalimumab for Crohn's disease.

    Hughes, D., Hughes, D. A., Bodger, K. & Kikuchi, T., 1 Ebr 2008.

    Allbwn ymchwil: Cyfraniad at gynhadledd › Papur

  31. Cyhoeddwyd

    Cost-effectiveness analysis of infliximab and adalimumab for Crohn's disease.

    Hughes, D., Hughes, D. A., Bodger, K. & Kikuchi, T., 1 Ebr 2008.

    Allbwn ymchwil: Cyfraniad at gynhadledd › Papur

  32. Cyhoeddwyd

    Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.

    Hughes, D., Hughes, D. A. & Dubois, D., 1 Ion 2004, Yn: Pharmacoeconomics. 22, 16, t. 1047-1059

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  33. Cyhoeddwyd

    Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis: Authors’ reply.

    Hughes, D., Culeddu, G., Plumpton, C., Wood, E., Dick, A. D., Beresford, M. W. & Ramanan, A. V., Maw 2019, Yn: Ophthalmology. 126, 3, t. e24-e25

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Llythyr › adolygiad gan gymheiriaid

  34. Cyhoeddwyd

    Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis

    Hughes, D. A., Culeddu, G., Plumpton, C. O., Wood, E., Dick, A. D., Jones, A. P., McKay, A., Williamson, P. R., Compeyrot Lacassagne, S., Hardwick, B., Hickey, H., Woo, P., Beresford, M. W. & Ramanan, A. V., Maw 2019, Yn: Ophthalmology. 126, 3, t. 415-424

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  35. Cyhoeddwyd

    Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity

    Hughes, D., Hughes, D. A., Vilar, F. J., Ward, C. C., Alfirevic, A., Park, B. K. & Pirmohamed, M., 1 Meh 2004, Yn: Pharmacogenetics. 14, 6, t. 335-342

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  36. Cyhoeddwyd

    Cost-effectiveness Analysis of the Dental RECUR Pragmatic Randomized Controlled Trial: Evaluating a Goal-oriented Talking Intervention to Prevent Reoccurrence of Dental Caries in Children

    Victory, E., Rhiannon, E. T., Girvan, B., Pauline, A. & Cynthia, P. M., Mai 2022, Yn: Applied Health Economics and Health Policy. 20, 3, t. 431-445 15 t.

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  37. Cyhoeddwyd

    Cost-effective optical coherence tomography spectrometer based on a tilted fiber Bragg grating

    Remund, S., Bossen, A., Chen, X., Wang, L., Adebayo, A., Zhang, L., Povazay, B. & Meier, C., 20 Chwef 2014.

    Allbwn ymchwil: Cyfraniad at gynhadledd › Papur

  38. Cyhoeddwyd

    Cost-effective models for delivering behaviour analysis teaching in UK schools and local authorities

    McCandless, S. & Hoerger, M., Meh 2022, Yn: British Journal of Special Education. 49, 2, t. 261-275

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  39. Cyhoeddwyd

    Cost-benefit analysis of continuous cover forestry

    Price, C. & Price, M., 1 Ion 2009, Yn: Scandinavian Forest Economics. 42, t. 36-65

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  40. Cyhoeddwyd

    Cost-Effectiveness of Pharmacogenetics-Guided Warfarin Therapy vs. Alternative Anticoagulation in Atrial Fibrillation

    Hughes, D., Pink, J., Pirmohamed, M., Lane, S. & Hughes, D. A., 23 Medi 2013, Yn: Clinical Pharmacology and Therapeutics.

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  41. Cyhoeddwyd

    Cost-Effectiveness and Cost–Benefit Analyses of Providing Menstrual Cups and Sanitary Pads to Schoolgirls in Rural Kenya

    Babagoli, M., Benshaul-Tolonen, A., Zulaika, G., Nyothach, E., Oduor, C., Obor, D., Mason, L., Kerubo, E., Ngere, I., Laserson, K., Edwards, R. T. & Phillips-Howard, P., 15 Medi 2022, Yn: Women's Health Reports. 3, 1, t. 773-784 12 t.

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  42. Cyhoeddwyd

    Cost-Effectiveness Of PET/CT In Pre-Operative Staging Of Pancreatic Cancer: An Economic Evaluation Of The PET-PANC Cohort Study

    Plumpton, C., Ghaneh, P., Lloyd-Williams, H., Yeo, S. T. & Edwards, R., Hyd 2017, Yn: Value in Health. 20, 9, t. A589

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl

  43. Cyhoeddwyd

    Cost-Effectiveness Analysis of the Use of Point-of-Care C-Reactive Protein Testing to Reduce Antibiotic Prescribing in Primary Care

    Holmes, E., Harris, S. D., Hughes, A., Craine, N. & Hughes, D., 7 Rhag 2018, Yn: Antibiotics. 7, 4, 19 t., 106.

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  44. Cyhoeddwyd

    Cost-Effectiveness Analysis of Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa

    Culeddu, G., Brogan, P. A. & Hughes, D., 2021.

    Allbwn ymchwil: Cyfraniad at gynhadledd › Arall › adolygiad gan gymheiriaid

  45. Cyhoeddwyd

    Cost recovery in urban high-density housing: a discourse with experiences from Zimbabwe

    Kamete, A. & Kamete, A. Y., 1 Ion 2000, Yn: Habitat International. 24, 3, t. 241-260

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  46. Cyhoeddwyd

    Cost of non-compliance and non-persistence with medications for diabetes mellitus

    Hughes, D., Salas, M., Hughes, D. A., Lebmeier, M. & Vardeva, K., 1 Awst 2007.

    Allbwn ymchwil: Cyfraniad at gynhadledd › Papur

  47. Cyhoeddwyd

    Cost of a deprived environment – increased intraspecific aggression and susceptibility to pathogen infections

    Masud, N., Ellison, A., Pope, E. & Cable, J., 22 Hyd 2020, Yn: Journal of Experimental Biology. 223, 20

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  48. Cyhoeddwyd

    Cost minimization of on-demand maintenance therapy with proton pump inhibitors in nonerosive gastroesophageal reflux disease.

    Hughes, D., Hughes, D. A., Marchetti, M. & Colombo, G., 1 Chwef 2005, Yn: Expert Review of Pharmacoeconomics and Outcomes Research. 5, 1, t. 29-38

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  49. Cyhoeddwyd

    Cost minimization of on-demand maintenance therapy with proton pump inhibitors in nonerosive gastroesophageal reflux disease

    Hughes, D. & Hughes, D. A., 1 Tach 2004, Yn: Value in Health. 7, 6, t. 753

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

  50. Cyhoeddwyd

    Cost estimation of optical amplifier technologies.

    Tang, J. & Tang, J. M., 1 Ion 2003, 2003 gol. Unknown.

    Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn

Blaenorol 1...453 454 455 456 457 458 459 460 ...579 Nesaf